Blythe Thomson, MD
Senior Vice President, Hematology & Oncology
Greg Hale, MD
Vice President, Hematology & Oncology
Ann Woolfrey, MD
Vice President, Hematology & Oncology
Francis LeBlanc, MD
Medical Director, Hematology & Oncology
Philip Roehrs, MD
Medical Director, Hematology & Oncology
Jennifer Pullum
Senior Executive Director, Clinical Trial Management
Jamie Meseke, DBA
Director, Clinical Trial Management
Your Next Breakthrough Starts Here
HEMATOLOGY & ONCOLOGY CRO
Through our proven full-service outsourcing model, Medpace consistently delivers high-quality results, showcasing profound expertise in managing Phase I-IV trials. Operating in over 45 countries, we have earned a reputation for taking on some of the most complex and challenging cancer research studies.
- Led by a team of medical, operational, and regulatory experts experienced in hematology and oncology
- Integrated services and systems through out wholly-owned Central Laboratories, Bioanalytical Lab, Imaging Core Lab, ECG Core Lab, and Phase I Unit, in addition to our Clinical Trial Management System
- Preferred provider relationships with key sites, expediting site start-up, enhancing recruitment, and maximizing trial efficacy
- Experience in targeted, advanced, and radiation therapies
